Crop Life Science reports FY26 net profit of ₹698.69 lakh

2 min read     Updated on 27 May 2026, 01:55 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Crop Life Science Limited reported a net profit of ₹698.69 lakh for FY26, up from ₹662.03 lakh in the previous year, with revenue rising to ₹20,717.42 lakh. The Board approved the audited financial results on May 26, 2026, receiving an unmodified opinion from statutory auditors. Consolidated net profit increased to ₹649.49 lakh, while total assets grew to ₹20,531.69 lakh.

powered bylight_fuzz_icon
41372697

*this image is generated using AI for illustrative purposes only.

Crop Life Science Limited reported a net profit of ₹698.69 lakh for the financial year ended March 31, 2026, an increase from ₹662.03 lakh in the previous year. Revenue from operations rose to ₹20,717.42 lakh for FY26, compared to ₹20,059.00 lakh in FY25. The company’s basic and diluted earnings per share stood at ₹4.08 for the year, up from ₹3.86 in the prior year.

The Board of Directors approved the audited standalone and consolidated financial statements for the half year and year ended March 31, 2026, at its meeting held on May 26, 2026. Shah & Shah, Chartered Accountants, issued an audit report with an unmodified opinion on the financial results. The statutory auditors confirmed that the results give a true and fair view in conformity with the Indian Accounting Standards.

Standalone Financial Performance

For the year ended March 31, 2026, total income stood at ₹20,888.52 lakh, a slight increase from ₹20,157.16 lakh in the previous year. Total expenses for the period were ₹19,904.37 lakh, compared to ₹19,256.08 lakh in FY25. The profit before exceptional items was ₹984.15 lakh, while exceptional items for the year amounted to ₹6.28 lakh.

Particulars Year Ended March 31, 2026 (₹ in Lacs) Year Ended March 31, 2025 (₹ in Lacs)
Revenue from operations 20,717.42 20,059.00
Total income 20,888.52 20,157.16
Total expenses 19,904.37 19,256.08
Net profit for the year 698.69 662.03
Basic EPS (₹) 4.08 3.86

Consolidated Financial Results

On a consolidated basis, the company reported a net profit of ₹649.49 lakh for FY26, up from ₹560.11 lakh in the previous year. Total consolidated revenue from operations was ₹20,717.42 lakh, matching the standalone figures. Profit attributable to the owners of the company stood at ₹663.51 lakh, while non-controlling interest was recorded at a loss of ₹14.02 lakh.

Particulars Year Ended March 31, 2026 (₹ in Lacs) Year Ended March 31, 2025 (₹ in Lacs)
Revenue from operations 20,717.42 20,059.00
Total income 20,894.42 20,160.73
Total expenses 19,977.48 19,381.15
Net profit for the year 649.49 560.11
Basic EPS (₹) 3.79 3.27

Financial Position and Cash Flows

The total assets of the company stood at ₹20,531.69 lakh as of March 31, 2026, up from ₹17,770.69 lakh in the previous year. Total equity increased to ₹8,534.52 lakh from ₹7,820.18 lakh. The net cash flow from operating activities was negative at ₹(791.45) lakh, primarily due to changes in working capital. The company reported a net increase in cash and cash equivalents of ₹1,555.31 lakh during the year.

Historical Stock Returns for Crop Life Science

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+6.51%-3.81%-15.00%-10.71%-16.84%

What strategies will the company implement to reverse the negative operating cash flow driven by working capital changes?

How does Crop Life Science plan to utilize the significant increase in total assets to drive future revenue growth?

Will the company maintain its current expense management strategy to sustain profit margins amidst rising operational costs?

CLSL seeks vote to regularize director Sheetalben Shah

1 min read     Updated on 22 May 2026, 12:58 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Crop Life Science Limited has announced a postal ballot notice to seek shareholder approval for the regularization of Ms. Sheetalben Rachit Shah as a Non-Executive Independent Director. The board meeting held on May 20, 2026, authorized the process, appointing Mr. Ranjit Kumar Singh as the Scrutinizer. The e-voting period is scheduled from May 26, 2026, to June 24, 2026, with results to be declared by June 26, 2026.

powered bylight_fuzz_icon
40886879

*this image is generated using AI for illustrative purposes only.

Crop Life Science Limited has announced a postal ballot notice to seek shareholder consent for the regularization of the appointment of Ms. Sheetalben Rachit Shah as a Non-Executive Independent Director. The company's board, which met on May 20, 2026, approved the necessary notices to facilitate this shareholder vote through remote e-voting.

The resolution proposes the appointment of Ms. Sheetalben Rachit Shah (DIN: 11633798) for a term of five years, effective from April 10, 2026, to April 09, 2031. She was initially appointed as an Additional Director by the board on April 10, 2026. The company has received a notice from a member proposing her candidature, and she has submitted a declaration confirming her independence.

Calendar of Events

The company has established May 15, 2026, as the cut-off date to determine shareholders eligible to participate in the e-voting process. To ensure the integrity of the process, Mr. Ranjit Kumar Singh, a Practicing Company Secretary from Vadodara, has been appointed as the Scrutinizer.

Sr. No. Particulars Date
1. Scrutinizer Consent Date May 15, 2026
2. Board Meeting Authorization Date May 20, 2026
3. Cut-off Date for E-voting Eligibility May 15, 2026
4. E-Voting Start Date May 26, 2026
5. E-Voting End Date June 24, 2026
6. Result Declaration Date On or before June 26, 2026

The remote e-voting facility will commence on May 26, 2026, at 9:00 A.M. IST and conclude on June 24, 2026, at 5:00 P.M. IST. The resolutions will be deemed to be passed on the closing date of the e-voting window. The Scrutinizer will submit the report, and the results will be declared on or before June 26, 2026.

Historical Stock Returns for Crop Life Science

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+6.51%-3.81%-15.00%-10.71%-16.84%

How might Ms. Sheetalben Rachit Shah's appointment influence Crop Life Science's corporate governance strategy and board composition over her five-year tenure?

What expertise or industry connections does Ms. Shah bring that could impact Crop Life Science's business direction in the agrochemical or life sciences sector?

How could the outcome of this shareholder vote reflect institutional investor sentiment toward Crop Life Science's current management and governance practices?

1 Year Returns:-10.71%